Real-world study of efficacy, risk management and reasons for discontinuation of natalizumab for treatment of multiple sclerosis in Russia
Evdoshenko, Evgeniy, Stepanova, Alexandra, Shumilina, Maria, Davydovskaya, Maria, Khachanova, Natalia, Neofidov, Nikolay, Kalinin, Ivan, Popova, Ekaterina, Dubchenko, Ekaterina, Pozhidaeva, Natalia, Volkov, Andrey, Sivertseva, Stella, Prilenskaya, Anna, Malkova, Nadezhda, Korobko, Denis, Vergunova, Ilona, Shchur, Sergey, Makshakov, Gleb
Published in PloS one (28.05.2019)
Published in PloS one (28.05.2019)
Get full text
Journal Article